Clinical Research Unit: Sign up for a clinical trial
The Neuro’s Clinical Research Unit (CRU) evaluates the efficacy of new drugs and treatment regimens. Many patients come to The Neuro because they want to have access to the newest medications and diagnostic procedures.
- Research Centres and Facilities
- Research Groups
- Interdisciplinary teams
- GBA-Quebec Study Group (G-QUEST)
Research Centres and Facilities
Neuro faculty members lead international research teams that generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology to brain imaging and cognitive neuroscience.
The Neuro’s multidisciplinary teams, including an additional 220 academic staff, generate fundamental information that spans the full spectrum of neuroscience from cell and molecular biology to brain imaging and cognitive neuroscience.
The programs listed below, offered in partnership with The Neuro, provide scientists and researchers with opportunities to engage in novel cross-disciplinary research, integrating neuroscience with principles of engineering and the physical sciences.
The Neuro Engineering Program and the Rio Tinto Laboratory of Neuro Engineering
The Neuro Engineering Program is a merger of physical and biological sciences. Together, physicists, chemists, materials scientists, computer engineers and neuroscientists tackle the challenges of creating interfaces between neurons and artificial substrates to restore the function of a damaged nervous system.
Visit their website
Canadian Neurophotonics Platform
The Neurophotonics Centre is a unique, state-of-the-art national facility for advanced Biophotonics approaches dedicated toward the understanding of the brain, the development of diagnostics for brain disorders and phototherapy. The centre brings together a team of researchers, scientists and staff who develop and use the most innovative methods integrating neuroscience and physics.
Visit their website
GBA-Quebec Study Group (G-QUEST) – Parkinson’s Disease
G-QUEST is the first group of scientists and clinicians who are dedicated to solving the numerous challenges in GBA-PD research. Together, we aim to facilitate the development of GBA-targeting drugs into phase I clinical trials by:
- Using different approaches than that typically used for drug development; and
- Testing new hypotheses
- Engaging the power of the Open Science collaborative approach